Latest news with #ARKInnovationETF
Yahoo
4 days ago
- Automotive
- Yahoo
Cathie Wood Is Buying Tesla Stock Here. Should You?
Tesla (TSLA) is seeing a chronic sales decline this year amidst rising competition from the likes of BYD (BYDDY), but this has not deterred influential investor Cathie Wood. The founder and chief executive of Ark Invest loaded up on nearly 60,000 TSLA shares late last week across two of her flagship funds: the ARK Innovation ETF (ARKK) and the ARK Next Generation Internet ETF (ARKW). Palantir Just Launched Warp Speed for Warships. Does That Make PLTR Stock a Buy? This Analyst Just Doubled His Price Target on AMD Stock How High Can Nvidia Stock Go as Jensen Huang Heads to China? Get exclusive insights with the FREE Barchart Brief newsletter. Subscribe now for quick, incisive midday market analysis you won't find anywhere else. At the time of writing, Tesla stock is down more than 13% down versus its three-month high. Cathie Wood investing more than $18 million in TSLA shares last week is notably positive for investors as it signals strong conviction in the company's long-term potential. Wood is bullish on the EV stock primarily because she sees transformative potential in its robotaxi and humanoid robot initiatives. According to her, autonomous services will drive up to 90% of the automaker's future value, with software-like margins exceeding 80%. Wood even has a long-term price target of $2,600 on Tesla stock, indicating relentless confidence in its innovation pipeline, including affordable EVs and artificial intelligence enabled mobility. Despite the company's launch of robotaxi services and progress on humanoid robots, UBS analyst Joseph Spak does not share Wood's optimism on Tesla stock. On Monday, Spak reiterated his 'Sell' rating on the EV stock, citing valuation concerns. TSLA has a forward price-earnings multiple of more than 230x currently – much higher than several top AI stocks, including Nvidia (NVDA), which trades at 41x forward earnings. Additionally, the investment firm cited the 'removal of 100% margin credit revenue, and a CEO who's arguably distracted from the business,' for its bearish view on Tesla stock. UBS currently has a $215 price target on Tesla that translates to potential downside of more than 30% from current levels. Other Wall Street analysts also remain dovish on TSLA shares – especially since the EV company reported a 14% year-over-year decline in quarterly deliveries in the first week of July. The consensus rating on Tesla stock currently sits at 'Hold' only with the mean target of $297 implying 5% downside from here. On the date of publication, Wajeeh Khan did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on
Business Insider
6 days ago
- Business
- Business Insider
Cathie Wood Pours $18.5M into Tesla Stock, Trims ACHR, Roku, and COIN Stocks
Popular investor Cathie Wood's ARK Invest made key portfolio moves on Friday, July 11, with electric vehicle giant Tesla (TSLA) leading the day's buys. At the same time, Wood continued to offload shares of electric aircraft maker Archer Aviation (ACHR), streaming platform Roku (ROKU), and cryptocurrency exchange Coinbase (COIN). Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. Wood Loads Up on Tesla Stock As per the daily trade disclosures, ARK added a total of 59,705 Tesla shares across its ARK Innovation ETF (ARKK) and ARK Next Generation Internet ETF (ARKW), amounting to a hefty $18.5 million investment. The buy highlights Wood's continued conviction in Tesla as a core long-term holding, especially amid growing interest in AI-powered autonomous vehicles. In another notable buy, the ARK Autonomous Technology & Robotics ETF (ARKQ), the firm's ETF focused on autonomous tech and robotics, made a sizable addition of 425,933 shares of Aurora Innovation (AUR), valued at $2.29 million. Aurora is a key player in the self-driving technology space. Is Tesla Stock a Buy or Sell Now? Overall, Wall Street is sidelined on Tesla stock, with a Hold consensus rating based on 14 Buys, 13 Holds, and nine Sell recommendations. The average TSLA stock price target of $295.80 indicates 5.65% downside risk from current levels. ARK Trims Stakes in Archer, Roku, and Coinbase On the sell side, ARK reduced its position in electric aircraft maker Archer Aviation (ACHR), selling 168,990 shares for roughly $1.82 million from ARKK. Meanwhile, the firm continued to trim its position in Roku and Coinbase stocks. On Friday, ARK sold 42,332 shares of ROKU worth $3.82 million across ARKK and ARKW ETFs. It also trimmed its Coinbase stake once again, offloading 5,596 shares for $2.17 million through the ARKW ETF. The transaction follows a larger sale of 16,627 shares on July 10, as ARK continued to scale back its position in the cryptocurrency exchange amid recent market volatility. Wall Street's Take on ACHR, ROKU, and COIN Turning to Wall Street, Archer stock scores a Moderate Buy consensus rating, with the average ACHR stock price target of $11.75 indicating an 11.80% possible decline from current levels. Coinbase also carries a Moderate Buy rating, with analysts' average COIN stock price target of $307.71 implying a possible 20.50% decline. In contrast, Roku shares have a Moderate Buy rating as well, but with an average ROKU stock price target of $93.79 that points to a potential upside of 5.39%.
Business Insider
12-07-2025
- Business
- Business Insider
Cathie Wood Pours $18.5M into Tesla Stock, Trims ACHR, Roku, and COIN Stocks, 7/12/2025
Popular investor Cathie Wood's ARK Invest made key portfolio moves on Friday, July 11, with electric vehicle giant Tesla (TSLA) leading the day's buys. At the same time, Wood continued to offload shares of electric aircraft maker Archer Aviation (ACHR), streaming platform Roku (ROKU), and cryptocurrency exchange Coinbase (COIN). Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. Wood Loads Up on Tesla Stock As per the daily trade disclosures, ARK added a total of 59,705 Tesla shares across its ARK Innovation ETF (ARKK) and ARK Next Generation Internet ETF (ARKW), amounting to a hefty $18.5 million investment. The buy highlights Wood's continued conviction in Tesla as a core long-term holding, especially amid growing interest in AI-powered autonomous vehicles. In another notable buy, the ARK Autonomous Technology & Robotics ETF (ARKQ), the firm's ETF focused on autonomous tech and robotics, made a sizable addition of 425,933 shares of Aurora Innovation (AUR), valued at $2.29 million. Aurora is a key player in the self-driving technology space. Is Tesla Stock a Buy or Sell Now? Overall, Wall Street is sidelined on Tesla stock, with a Hold consensus rating based on 14 Buys, 13 Holds, and nine Sell recommendations. The average TSLA stock price target of $295.80 indicates 5.65% downside risk from current levels. ARK Trims Stakes in Archer, Roku, and Coinbase On the sell side, ARK reduced its position in electric aircraft maker Archer Aviation (ACHR), selling 168,990 shares for roughly $1.82 million from ARKK. Meanwhile, the firm continued to trim its position in Roku and Coinbase stocks. On Friday, ARK sold 42,332 shares of ROKU worth $3.82 million across ARKK and ARKW ETFs. It also trimmed its Coinbase stake once again, offloading 5,596 shares for $2.17 million through the ARKW ETF. The transaction follows a larger sale of 16,627 shares on July 10, as ARK continued to scale back its position in the cryptocurrency exchange amid recent market volatility. Wall Street's Take on ACHR, ROKU, and COIN Turning to Wall Street, Archer stock scores a Moderate Buy consensus rating, with the average ACHR stock price target of $11.75 indicating an 11.80% possible decline from current levels. Coinbase also carries a Moderate Buy rating, with analysts' average COIN stock price target of $307.71 implying a possible 20.50% decline. In contrast, Roku shares have a Moderate Buy rating as well, but with an average ROKU stock price target of $93.79 that points to a potential upside of 5.39%.
Yahoo
09-07-2025
- Business
- Yahoo
Innovation ETF (ARKK) Hits New 52-Week High
For investors seeking momentum, ARK Innovation ETF ARKK is probably on the radar. The fund just hit a 52-week high and is up about 92.4% from its 52-week low price of $36.85/share. But are more gains in store for this ETF? Let's take a quick look at the fund and the near-term outlook on it to get a better idea of where it might be headed: ARK Innovation ETF provides thematic multi-cap exposure to 'disruptive innovation.' It is an actively managed fund investing in companies that benefit from the development of new products or services, technological improvements and advancements in scientific research related to the areas of DNA technologies and genomic revolution, automation, robotics, energy storage, artificial intelligence, next-generation Internet and Fintech innovation. ARKK charges 75 bps in annual fees (see: all the Broad Developed World ETFs here). This ETF has been an area to watch lately, given Cathie Wood's, the high-profile CEO of Ark Investment Management, explosive moves in a few stock holdings of ARKK. Cathie Wood continued its active bets on disruptive innovation by purchasing shares of CRISPR Therapeutics AG CRSP and selling 908 Devices Inc. MASS and Roku Inc. ROKU. This move reinforces ARK's long-standing bullish stance on gene-editing technologies. ARK also bought a few shares of Beam Therapeutics Inc. BEAM, reflecting evolving conviction in the future of biotech innovation. Cathie Wood remains bullish on the transformative power of emerging technologies despite the market turbulence. ARKK might remain strong going ahead, given a weighted alpha of 60.23 and a higher 20-day volatility of 29.55%. There is definitely some promise for investors who want to ride on this surging ETF. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Beam Therapeutics Inc. (BEAM) : Free Stock Analysis Report ARK Innovation ETF (ARKK): ETF Research Reports CRISPR Therapeutics AG (CRSP) : Free Stock Analysis Report Roku, Inc. (ROKU) : Free Stock Analysis Report 908 Devices Inc. (MASS) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research
Yahoo
09-07-2025
- Business
- Yahoo
Cathie Wood shells out $13.9 million for one high-stakes biotech stock
Cathie Wood shells out $13.9 million for one high-stakes biotech stock originally appeared on TheStreet. Amid all the noise over tariffs and rate-cut chatter, the smartest move is often to follow investors who've done it before. 💵💰💰💵 Love her or hate her, Cathie Wood is a true maverick who's made a name finding tomorrow's big disruptors long before anyone else. Now, with a fresh swing at a major biotech stock, it says a lot about where she thinks the next big win will come from. Cathie Wood's love affair with biotech stocks has been part of ARK's DNA since day one. Long before CRISPR became a Wall Street buzzword, Wood's team has been busy, scooping up shares in early-stage gene-editing names. Her Genomic Revolution ETF, ARKG, was one of ARK's first thematic funds, which made a splash by loading up on companies like Editas Medicine and Intellia Therapeutics. The idea was clear: Programmable gene-editing tools could effectively flip medicine from symptom treatment to real cures. That early leap paid off 2019 and 2020, ARKG posted massive gains, led by positive trial results and big-name pharma partnerships, while broader markets were stuck in neutral. Wood has been consistent in backing her biotech picks, regardless of bad trial news or cash crunches. For her, the appeal of gene editing has more to do with rewriting what health care looks like. She sees CRISPR and next-gen editing tools as critical tools in curing diseases outright, cutting treatment costs, while giving patients their lives back. Such a strategy comes with its fair share of risk, but Wood spreads that risk across multiple platforms. For those who back game-changing science, her biotech playbook is clear and effective at spotting revolutionary picks that typically stun Mr. Market. Cathie Wood kicked off what's been a choppy week with a classic ARK move, in loading big on a key biotech stock while locking in gains elsewhere. On Monday, ARK Invest scooped up 659,000 shares of Beam Therapeutics () , splitting the buy between Wood's flagship ARK Innovation ETF and the ARK Genomic Revolution ETF. More Tech Stock News: Google's quiet AI win spells trouble for Amazon Nvidia-backed stock sends a quiet shockwave through the AI world Veteran Tesla analyst drops 4-word call That comes to more than $13 million in fresh Beam stock, following a relatively smaller buy earlier this week worth roughly $571,000. Beam Therapeutics stands out in the ARK portfolio for good reason. Its robust base-editing technology promises remarkably more precise and safer gene edits than standard of slicing through both strands of DNA, Beam's method efficiently swaps out tiny pieces one at a time, making it a lot safer and more precise. That competitive edge has major stakes. Beam's pipeline includes programs for monogenic disorders including sickle cell and beta-thalassemia, along with multiple readouts lined up for this year. Beam's cash position is another plus for Wood, with the business funded into 2027, easing dilution fears that typically rattle biotech names. Also, a major Pfizer partnership in cardiovascular disease adds new layers to Beam's commercial push, while landing it even more credibility on the stock market. Hence, for Wood, Beam essentially ticks every box. Its powerful disruptive science, tangible milestones, and huge upside potential suggest a long-term winner. It's exactly the kind of swing-for-the-fences bet ARK is famous for and has made many millionaires in the process. On the flip side, Wood's team lightened up on Roblox () , selling 31,416 shares worth roughly $3.25 million of the popular gaming stock as it rebounded. That follows ARK's moves last week, where it sold 26,877 shares of the gaming giant. As always, biotech isn't for the faint-hearted, but for Cathie Wood, Beam is the moonshot that's in position to rewrite Wood shells out $13.9 million for one high-stakes biotech stock first appeared on TheStreet on Jul 8, 2025 This story was originally reported by TheStreet on Jul 8, 2025, where it first appeared.
